TP53 and cancer: Additionally, a pan-cancer integrative analysis identified several regulatory single-nucleotide polymorphisms (e.g., rs1239349555, rs1576326380, and rs56255137) in the 5′/3′ untranslated regions (UTRs) of KIAA1524 that are associated with CIP2A overexpression, and linked CIP2A regulatory networks with tumor protein p53 (TP53) mutations [23].